These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1391 related articles for article (PubMed ID: 8793189)

  • 81. Differential response of human melanoma and Ehrlich ascites cells in vitro to the ribosome-inactivating protein luffin.
    Poma A; Miranda M; Spanò L
    Melanoma Res; 1998 Oct; 8(5):465-7. PubMed ID: 9835461
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mortality of doctors in different specialties: findings from a cohort of 20000 NHS hospital consultants.
    Carpenter LM; Swerdlow AJ; Fear NT
    Occup Environ Med; 1997 Jun; 54(6):388-95. PubMed ID: 9245944
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Regulation of melanogenesis in B16 mouse melanoma cells by protein kinase C.
    Mahalingam H; Vaughn J; Novotny J; Gruber JR; Niles RM
    J Cell Physiol; 1996 Sep; 168(3):549-58. PubMed ID: 8816909
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation.
    Yokota T; Nishio H; Kubota Y; Mizoguchi M
    Pigment Cell Res; 1998 Dec; 11(6):355-61. PubMed ID: 9870547
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 86. New aspects of immunotherapy of leptomeningeal metastasis.
    Herrlinger U; Weller M; Schabet M
    J Neurooncol; 1998; 38(2-3):233-9. PubMed ID: 9696377
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A big gene linked to small eyes encodes multiple Mitf isoforms: many promoters make light work.
    Yasumoto K; Amae S; Udono T; Fuse N; Takeda K; Shibahara S
    Pigment Cell Res; 1998 Dec; 11(6):329-36. PubMed ID: 9870544
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Human epidermal melanocyte and keratinocyte melanotropin receptors: visualization by melanotropic peptide conjugated macrospheres (polyamide beads).
    Jiang J; Sharma SD; Hruby VJ; Fink JL; Hadley ME
    Exp Dermatol; 1997 Feb; 6(1):6-12. PubMed ID: 9067701
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma.
    Schultz MZ; Buzaid AC; Poo WJ
    Melanoma Res; 1997 Apr; 7(2):147-51. PubMed ID: 9167181
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Posterior uveal melanoma. The Swedish perspective.
    Seregard S
    Acta Ophthalmol Scand; 1996 Aug; 74(4):315-29. PubMed ID: 8883543
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Low-dose intravenous bolus interleukin-2 with interferon-alpha therapy for metastatic melanoma and renal cell carcinoma.
    Karp SE
    J Immunother; 1998 Jan; 21(1):56-61. PubMed ID: 9456437
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Recurrent lentigo maligna invading a skin graft successfully treated with Mohs' micrographic surgery.
    Cohen LM; Zax RH
    Cutis; 1996 Mar; 57(3):175-8. PubMed ID: 8882016
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Combined surgery and cryotherapy for melanoma of the conjunctiva: 37 months' follow-up.
    Cagini C; Menduno P; Ignagni S
    Eur J Ophthalmol; 1996; 6(3):343-5. PubMed ID: 8908446
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Synthesis and activity of partial retro-inverso analogs of the antimetastatic laminin-derived peptide, YIGSR-NH2.
    Zhao M; Kleinman HK; Mokotoff M
    J Pept Res; 1997 Mar; 49(3):240-53. PubMed ID: 9151257
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Differential regulation of HLA-DR expression and antigen presentation in Toxoplasma gondii-infected melanoma cells by interleukin 6 and interferon gamma.
    Yang TH; Aosai F; Norose K; Ueda M; Yano A
    Microbiol Immunol; 1996; 40(6):443-9. PubMed ID: 8839430
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
    Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
    Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Combined treatment of stage IV melanoma patients with amifostine and fotemustine--a pilot study.
    Mohr P; Makki A; Breitbart E; Schadendorf D
    Melanoma Res; 1998 Apr; 8(2):166-9. PubMed ID: 9610871
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cancer vaccines. Part 2.
    Hallin PA; Adams VR
    J Am Pharm Assoc (Wash); 1997; NS37(6):706-9. PubMed ID: 9425801
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
    Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
    Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.